Patients with CCUS-like ( P = .01) and SF3B1 ( P < .0001) were less likely to be treated with HMA or more intensive therapies, whereas those with bi-TET2 ( P = .09) and del5q ( P = .06) showed a trend toward being treated less often with HMA or intensive therapies.
← all excerpts
Application of the International Working Group MDS molecular taxonomy classes to a single institution cohort.
1
—
—